(19)
(11) EP 3 986 431 A1

(12)

(43) Date of publication:
27.04.2022 Bulletin 2022/17

(21) Application number: 20751824.2

(22) Date of filing: 18.06.2020
(51) International Patent Classification (IPC): 
A61K 35/74(2015.01)
A61K 9/20(2006.01)
A61P 37/08(2006.01)
A61K 45/06(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 35/74; A61P 37/08; A61K 45/06; A61K 9/0019; A61K 9/2004; A61K 9/2072; A61K 9/4816
(86) International application number:
PCT/US2020/038335
(87) International publication number:
WO 2020/257390 (24.12.2020 Gazette 2020/52)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 21.06.2019 US 201962864886 P
04.10.2019 US 201962910920 P

(71) Applicant: Evelo Biosciences, Inc.
Cambridge, MA 02139 (US)

(72) Inventors:
  • CORMACK, Taylor, A.
    Cambridge, MA 02139 (US)
  • ITANO, Andrea
    Cambridge, MA 02139 (US)
  • PONICHTERA, Holly
    Cambridge, MA 02139 (US)
  • RAMANI, Kritika
    Cambridge, MA 02139 (US)

(74) Representative: J A Kemp LLP 
80 Turnmill Street
London EC1M 5QU
London EC1M 5QU (GB)

   


(54) COMPOSITIONS AND METHODS OF TREATING A TH2-MEDIATED CONDITION USING PREVOTELLA